Be'eri Niego Australian Centre for Blood Diseases Monash University Biography Publications Institution JoVE Articles Be'eri Niego has not added a biography. If you are Be'eri Niego and would like to personalize this page please email our Author Liaison for assistance. Publications T-PA-specific Modulation of a Human Blood-brain Barrier Model Involves Plasmin-mediated Activation of the Rho Kinase Pathway in Astrocytes Blood. May, 2012 | Pubmed ID: 22262761 Thrombin-induced Activation of Astrocytes in Mixed Rat Hippocampal Cultures is Inhibited by Soluble Thrombomodulin Brain Research. Mar, 2011 | Pubmed ID: 21241677 A Nonfibrin Macromolecular Cofactor for TPA-mediated Plasmin Generation Following Cellular Injury Blood. Aug, 2009 | Pubmed ID: 19584397 Tissue-type Plasminogen Activator Requires a Co-receptor to Enhance NMDA Receptor Function Journal of Neurochemistry. Nov, 2008 | Pubmed ID: 18796005 Desmoteplase-mediated Plasminogen Activation and Clot Lysis Are Inhibited by the Lysine Analogue Tranexamic Acid Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis. Jun, 2008 | Pubmed ID: 18469556 Two Conserved Regions Within the Tissue-type Plasminogen Activator Gene Promoter Mediate Regulation by Brain-derived Neurotrophic Factor The FEBS Journal. May, 2007 | Pubmed ID: 17419735 Oncostatin M is a Neuroprotective Cytokine That Inhibits Excitotoxic Injury in Vitro and in Vivo FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Nov, 2006 | Pubmed ID: 17023520 Effective Treatment of Mouse Metastatic Prostate Cancer by Low Electric Field Enhanced Chemotherapy The Prostate. Nov, 2006 | Pubmed ID: 16941466 Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier Be'eri Niego1, Robert L. Medcalf1 1Australian Centre for Blood Diseases, Monash University JoVE 50934 Bio-ingénierie
Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier Be'eri Niego1, Robert L. Medcalf1 1Australian Centre for Blood Diseases, Monash University JoVE 50934 Bio-ingénierie